| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.23 | 7e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |